Jacobs Levy Equity Management
AMLX icon

Jacobs Levy Equity Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Jacobs Levy Equity Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-77,091
Closed -$273K – 1031
2025
Q1 		$273K Sell
77,091
-237,848
-76% -$842K ﹤0.01% 993
2024
Q4 		$1.19M Sell
314,939
-163,501
-34% -$618K ﹤0.01% 689
2024
Q3 		$1.55M Sell
478,440
-110,671
-19% -$359K 0.01% 648
2024
Q2 		$1.12M Buy
+589,111
New +$1.12M ﹤0.01% 707